Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
37.65%Capital Expenditures Margin
VS
Market
Sector
Industry
History
$ 3.96Close
$ 3.57 - $ 19.8 52-Week Range
Ticker Information
Ticker
CLSDCompany Name
CLEARSIDE BIOMEDICAL INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCLEARSIDE BIOMEDICAL INC - Capital Expenditures Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CLSD - CapEx % Historical data
| Date | Capital Expenditure | Capital Expenditures Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 506K | 37.65% | $ 1.34M |
| 3/31/2025 | $ 929K | 64.78% | $ 1.43M |
| 12/31/2024 | $ 977K | 58.71% | $ 1.66M |
| 9/30/2024 | $ 653K | 8.48% | $ 7.7M |
| 6/30/2024 | $ 1.04M | 13.89% | $ 7.52M |
| 3/31/2024 | $ 1.72M | 20.34% | $ 8.45M |
| 12/31/2023 | $ 1.78M | 21.6% | $ 8.23M |
| 9/30/2023 | $ 1.75M | 79.06% | $ 2.21M |
| 6/30/2023 | $ 1.46M | 90.11% | $ 1.62M |
| 3/31/2023 | $ 361K | 36.69% | $ 984K |
Key Performance Insights, Last 5 Years
- CLEARSIDE BIOMEDICAL INC's latest trailing twelve months (TTM) CapEx % stands at 0.56%.
- Over the past 5 years, CLEARSIDE BIOMEDICAL INC's average CapEx % has been 32.26%.
- The median CapEx % for CLEARSIDE BIOMEDICAL INC during this period was 20.97%
- CLEARSIDE BIOMEDICAL INC reached its highest CapEx % over the past 5 years at 90.11%.
- The lowest CapEx % recorded by CLEARSIDE BIOMEDICAL INC in the same timeframe 0.56%
CLEARSIDE BIOMEDICAL INC's CapEx % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx % Benchmarks
Similar metrics to Revenues:
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditure - [Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.
- Capital Expenditures Coverage - [Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Cost of Revenue Margin - [Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.
Definition of Capital Expenditures Margin
[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].CapEx / Revenues
(=) CapEx % CapEx % for CLEARSIDE BIOMEDICAL INC is calculated as follows: CapEx [ $ 55K ] / Revenues [ $ 9.82M ]
(=) CapEx % [ 0.56% ] CLSD - Capital Expenditures Margin, Last 5 years
0.56%
Minimum
Sep 30, 2020
90.11%
Maximum
Jun 30, 2023
32.26%
Average
20.97%
Median
CapEx % Benchmark AnalysisMarket
The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.47% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
| filtered constituents | 2.85K |
|---|---|
| min | 0% |
| max | 15.02% |
| average | 3.47% |
| median | 2.43% |
| std | 3.27% |